Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-01-30
1992-10-13
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544236, A61K 31495, C07D48700
Patent
active
051551080
ABSTRACT:
The imidazo[1,2-b]pyridazine compounds of the formula: ##STR1## wherein R.sub.1 is a hydrogen or halogen atom, or a lower alkyl group optionally having substituent(s), R.sub.2 an R.sub.3 are, independently, a hydrogen atom, a lower alkyl group optionally having substituent(s), a cycloalkyl group or a phenyl group optionally having substituent(s) or R.sub.2 and R.sub.3 together with the adjacent nitrogen atom to which they bond may form a heterocyclic ring optionally having substituent(s), X is an oxygen atom or S(O)n (n=0 to 2), Alk is a straight or branched chain alkylene group containing 1-10 carbon atoms and optionally having substituent(s), or their pharmaceutically acceptable salts which possess antiallergic, anti-inflammatory and anti-PAF activities, and their production and use.
REFERENCES:
patent: 4307094 (1981-12-01), Hassall et al.
Kuriki Hisashi
Kuwahara Masaaki
Miyake Akio
Lee Mary C.
Takeda Chemical Industries Ltd.
Whittenbaugh Robert C.
LandOfFree
Imidazopyridazines and use as antiasthmatic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridazines and use as antiasthmatic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridazines and use as antiasthmatic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1300583